DIFFERENTIAL EFFICACY OF BORTEZOMIB IN SUBTYPES OF DIFFUSE LARGE B‐CELL LYMPHOMA (DLBL): a PROSPECTIVE RANDOMISED STUDY STRATIFIED BY TRANSCRIPTOME PROFILING: REMODL‐B | Zendy

Davies A.J. | Zendy; Barrans S. | Zendy; Maishman T. | Zendy; Cummin T.E. | Zendy; Bentley M. | Zendy; Mamot C. | Zendy; Novak U. | Zendy; Caddy J. | Zendy; Hamid D. | Zendy; KazmiStokes S.H. | Zendy; Mcmillan A. | Zendy; Fields P.A. | Zendy; Pocock C. | Zendy; Kruger A. | Zendy; Collins G. | Zendy; Sha C. | Zendy; Clipson A. | Zendy; Wang M. | Zendy; Tooze R.M. | Zendy; Care M.A. | Zendy; Griffiths G.O. | Zendy; Du M. | Zendy; Westhead D.R. | Zendy; Burton C. | Zendy; Jack A. | Zendy; Johnson P.W. | Zendy

Premium

DIFFERENTIAL EFFICACY OF BORTEZOMIB IN SUBTYPES OF DIFFUSE LARGE B‐CELL LYMPHOMA (DLBL): a PROSPECTIVE RANDOMISED STUDY STRATIFIED BY TRANSCRIPTOME PROFILING: REMODL‐B

Author(s) -

Davies A.J.,

Barrans S.,

Maishman T.,

Cummin T.E.,

Bentley M.,

Mamot C.,

Novak U.,

Caddy J.,

Hamid D.,

KazmiStokes S.H.,

Mcmillan A.,

Fields P.A.,

Pocock C.,

Kruger A.,

Collins G.,

Sha C.,

Clipson A.,

Wang M.,

Tooze R.M.,

Care M.A.,

Griffiths G.O.,

Du M.,

Westhead D.R.,

Burton C.,

Jack A.,

Johnson P.W.

Publication year - 2017

Publication title -

hematological oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.918

H-Index - 44

eISSN - 1099-1069

pISSN - 0278-0232

DOI - 10.1002/hon.2437_120

Subject(s) - diffuse large b cell lymphoma , bortezomib , medicine , chop , oncology , clinical endpoint , transcriptome , population , germinal center , lymphoma , progression free survival , gastroenterology , biology , b cell , clinical trial , immunology , overall survival , gene expression , multiple myeloma , genetics , gene , environmental health , antibody

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research